数据驱动的早期类风湿关节炎亚组识别:挪威西部队列的心血管疾病与死亡风险
研究纳入2002-2013年诊断并随访至2022年的873例早期类风湿关节炎患者,用29个变量在诊断后1年进行潜在类别分析,识别出4个亚组;与「年轻起病」组相比,「心血管代谢」组(HR 2.14,95%CI 1.20-3.79)和「老年起病」组(HR 1.89,95%CI 1.07-3.35)主要心血管事件风险升高,仅「心血管代谢」组死亡风险升高(HR 1.79,95%CI 1.12-2.87)。
要点
- 早期RA可分出心血管代谢、老年起病、经典和年轻起病4个亚组。
- 心血管代谢组与老年起病组主要心血管事件风险均较年轻起病组升高。
- 仅心血管代谢组死亡风险较年轻起病组升高。
核心结论
- 识别出4个临床特征和结局不同的亚组,凸显数据驱动分类在早期RA中的可行性。
- 心血管代谢组和老年起病组主要心血管事件风险相似且较高,但后者DMARDs、降压药和他汀使用较少,提示RA和心血管疾病危险因素均存在治疗不足。
研究设计与样本
- 纳入2002-2013年诊断的早期类风湿关节炎患者,随访至2022年。
- 使用29个变量(不包括年龄)在RA诊断后1年进行潜在类别分析,识别亚组。
- 采用Cox回归校正年龄和性别,比较各组主要心血管事件(4p-MACE)、死亡、急性冠脉综合征和卒中的风险。
主要发现
- 在873例早期RA患者中识别出4个亚组:心血管代谢组(19%),以心血管疾病和糖尿病高患病率为特征。
- 老年起病组(20%),以风湿性多肌痛高患病率、抗环瓜氨酸蛋白抗体(ACPA)阴性和DMARDs使用较少为特征。
- 经典组(26%),以广泛关节受累和最高C反应蛋白(CRP)水平为特征。
- 年轻起病组(35%),以ACPA阳性和回纹型关节炎为特征。
- 与年轻起病组相比,心血管代谢组主要心血管事件风险升高(HR 2.14,95%CI 1.20-3.79),老年起病组亦升高(HR 1.89,95%CI 1.07-3.35);仅心血管代谢组死亡风险升高(HR 1.79,95%CI 1.12-2.87)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To identify subgroups of early rheumatoid arthritis (RA) based on comorbidities and RA manifestations and to investigate their associated risks of cardiovascular events and mortality. METHODS: We included patients with incident RA, diagnosed during 2002-2013 and followed through 2022. Latent class analysis was performed using 29 variables (excluding age) to identify subgroups 1 year after RA diagnosis. Risk of major cardiovascular events (4p-MACE), death, acute coronary syndrome and stroke was compared between groups using Cox regression adjusting for age and sex. RESULTS: Four subgroups were identified in a cohort of 873 patients with early RA: a 'cardiometabolic' group (19%), characterised by a high prevalence of cardiovascular disease (CVD) and diabetes; an 'elderly-onset' group (20%), with a high prevalence of polymyalgia rheumatica, anticitrullinated protein antibodies (ACPAs) negativity and less use of disease-modifying antirheumatic drugs (DMARDs); a 'classic' group (26%) with extensive joint involvement and the highest C reactive protein (CRP) levels and a 'young-onset' group (35%) characterised by ACPA positivity and palindromic arthritis.Compared to the 'young-onset' subgroup, both the 'cardiometabolic' (HR 2.14, 95% CI 1.20 to 3.79) and 'elderly-onset' subgroups (HR 1.89, 95% CI 1.07 to 3.35) had increased MACE risk. However, only the 'cardiometabolic' subgroup had increased mortality risk (HR 1.79, 95% CI 1.12 to 2.87). CONCLUSION: Four distinct subgroups were identified with different clinical profiles and outcomes. This underscores the feasibility of data-driven classification in early RA. The 'cardiometabolic' and 'elderly-onset' subgroups had similarly high MACE risk, but the latter used less DMARDs, antihypertensives and statins, suggesting undertreatment of both RA and CVD risk factors.
引用
- Alsing CL, Igland J, Nystad TW, et al. Data-driven identification of subgroups in early rheumatoid arthritis: mortality and cardiovascular disease in a cohort from western Norway. RMD Open. 2025. PMID: 41005975. doi:10.1136/rmdopen-2025-005905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。